Bibliografisk träff 2013-10-11 Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis. Ji N, Somanaboeina A, Dixit A, Kawamura K, Hayward NJ, Self C, Olson GL, Forsthuber TG. J Immunol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.4049/jimmunol.1300407